Abstract. Human antigen R (HuR) is a post-translational modifier of mRNAs rich in AU-and U-rich elements. These mRNAs typically code for proteins involved in cell growth and differentiation, signal transduction, transcriptional and translational control, apoptosis, nutrient transport and metabolism. Thus, HuR affects a variety of biological functions and processes. Via its effect on growth and cellular migration, HuR has been shown to enhance clinical progression of a number of cancers. Its role in wound healing remains unknown. In the present study, we evaluated HuR tissue expression in a cohort of chronic healed and non-healed leg ulcers. We also evaluated the effect of HuR knockdown on a number of cellular processes using the HaCaT human keratinocyte cell line. HuR was expressed in greater levels in the 'chronic healed' cohort of ulcers, compared to the 'chronic non-healed', although this failed to reach statistical significance (p= 0.13). HuR knockdown resulted in greater cellular growth, faster progression through the cell cycle and reduced apoptosis. Furthermore, it reduced cellular adhesion rates without affecting migration. We, therefore, concluded that HuR promotes wound healing, primarily through its effect on cellular adhesion. It also slows cellular growth rate via its effect on both cell cycle progression and rates of apoptosis.
Introduction
Human antigen R (HuR) was first cloned and identified as a member of the Hu family in 1996 (1); it was localised to chromosome 19 a year later (2) . The Hu family is composed of the neuronal Hu proteins HuB, HuC and HuD, as well as the ubiquitously expressed protein HuR (2) . The three neuronal Hu proteins, only expressed in differentiated neurons, play important roles in neuronal plasticity and differentiation. In humans, HuR is widely expressed in all proliferating cells. The Hu protein family shares homology with the Drosophila embryonic lethal abnormal vision (ELAV) proteins, and are thus occasionally referred to as the Hu/ELAV family (3) . The HuR protein contains three RNA recognition motifs (RRMs 1-3) which share a >90% amino acid sequence identity with other Hu family members (4) . RRM1 and 2 bind to the AU-and U-rich elements (also known as AREs) of mRNA, while RRM3 is thought to bind to the poly A tail and promote stability of the protein/mRNA complex (5) (6) (7) . HuR also contains a variable basic hinge region between RRM2 and RRM3, which contains the HuR nucleo-cytoplasmic shuttling sequence (HNS). This sequence allows HuR to shuttle mRNA between the nucleus and cytoplasm (8) . It is this ability of HuR to transport mRNAs rich in AREs, and thus alter their expression, which allows it to affect a number of biological functions. Many ARE-rich mRNAs encode functionally diverse proteins, including proteins regulating cell growth and differentiation, signal transduction, transcriptional and translational control, haematopoiesis, apoptosis, nutrient transport and metabolism (9) . A number of these functions contribute to carcinogenesis, and elevated HuR levels have been associated with a poorer prognosis in colonic (10) , breast (11) , ovarian (12, 13) and gastric carcinoma (14) (reviewed in ref. 15) .
Wound healing is a complex co-ordinated response to injury, which is divided into four overlapping phases: haemostasis, inflammation, proliferation and maturation (16) . Failure or prolongation of one or more phases results in either healing delay or non-closure of the wound. Chronic wounds present a serious problem to both the patient and the physician -they are a source of much morbidity and even mortality, they are costly to treat and can be difficult to manage (17) . The dynamic cellular events during the process of wound healing requires co-ordinated gene and protein expression at a time-and location-dependent manner. Thus, regulation of mRNA, the key function of HuR, during the healing process is essential. HuR has not been previously studied in the context of wound healing. In this study, we firstly analysed HuR transcript levels in wound tissues, and, secondly, we evaluated the effects of HuR knockdown on cellular functions using the human keratinocyte 'HaCaT' cell line.
Materials and methods

Cells and tissues.
The HaCaT human keratinocyte cell line was purchased from the German Cancer Institute. These cells were routinely cultured in DMEM/Ham's F12 with L-glutamine medium (PAA Laboratories, Somerset, UK), supplemented with streptomycin, penicillin and 10% foetal calf serum (PAA Laboratories), and incubated at 37˚C in 5% CO 2 and 95% humidity. Human wound tissues were collected from patients who attended wound clinics at the University Hospital of Wales, with the approval of the South East Wales Local Research Ethics Committee. Core biopsies were taken from the wound edge, and were immediately stored at -80˚C and subsequently in liquid nitrogen, until used. The wound tissues were all chronic (present for a minimum of 3 months despite conservative treatment) and of venous ulcer aetiology. They were biopsied at the time of the visit to the clinic (time zero), after which patients were treated and followed up routinely. Wounds that healed within 3 months of their initial visit were classified as 'Chronic healed', whereas those which failed to heal within the time frame were termed 'Chronic non-healed'. The samples were anonymised before processing and only decoded after the final test. Our wound tissue cohort comprised 51 chronic non-healing wounds and 20 chronic healed wounds.
Total cellular RNA preparation. Total cellular RNA was isolated from the homogenized tissue samples and human cell lines using the TRI reagent (Sigma, Dorset, UK), according to the manufacturer's protocol. Following extraction, the RNA concentration was quantified through spectrophotometric measurement (WPA UV 1101; Biotech Photometer, Cambridge, UK).
Reverse transcription-polymerase chain reaction (RT-PCR).
cDNA was generated from 250 ng of each RNA sample and reverse transcription was undertaken using an enhanced avian RT-PCR-100 kit with anchored oligo(dt) primers (Sigma). The quality of cDNA was verified using primers to detect the housekeeping gene GAPDH (full primer sequences are outlined in Table I ). Conventional PCR was performed in a T-Cy Thermocycler (Creacon Technologies Ltd., CD Emmen, The Netherlands) using REDTaq ® ReadyMix™ PCR Reaction Mix (Sigma).
PCR conditions were as follows: denaturing at 94˚C for 30 sec, annealing at 55˚C for 30 sec and extension at 72˚C for 30 sec. PCR was conducted over 38 cycles with an initial 5-min denaturing step (94˚C) and a final 10-min extension step (72˚C), and stored until required at 4˚C. The PCR products were then loaded into a 0.8% agarose gel, separated electrophoretically, stained with ethidium bromide and visualised under ultraviolet light.
Quantitative-polymerase chain reaction (Q-PCR).
The iCycler IQ system (Bio-Rad, Hertfordshire, UK) was used to detect and quantify the number of HuR transcripts in the wound specimens (18), as previously described (19, 20) . The results are provided as copy number/µl based on an internal standard. The results were further normalised against the expression of GAPDH in these samples. The Q-PCR technique used the Amplifluor system (Intergen Inc., Purchase, NY, USA), Q-PCR Master Mix (ABgene, Surrey, UK) and a universal probe (Uniprimer™; Intergen) to record the fluorescence emitted by the z-sequences. Conditions for Q-PCR were an initial period of 15 min at 95˚C, followed by 80 cycles of 95˚C for 15 sec, 55˚C for 60 sec and 72˚C for 20 sec. Full details of the primers used are outlined in Table I .
Generation of HuR knockdown in human keratinocyte cell lines.
Anti-human HuR hammerhead ribozymes were designed based on the secondary structure of HuR mRNA, generated using the Zuker RNA mFold program (21) . The ribozymes were synthesized and cloned into a pEF6/V5-His-TOPO plasmid vector (Invitrogen, Paisley, UK). An appropriate ribozyme transgene and empty pEF6 control plasmid were transfected into HaCaT cells, as previously reported (22, 23) . Following transfection and blasticidin selection, cells were subsequently cultured in maintenance medium and routinely tested to confirm knockdown of HuR expression. HaCaT cells containing the ribozyme transgenes and the control PEF plasmids were designated as HaCaT HuR knockdown and HaCaT PEF, respectively.
SDS-PAGE and Western blotting.
Following lysis of cells, equal amounts of protein from each sample were separated on a 10% acrylamide gel. Proteins were probed using the respective primary antibodies at a concentration of 1:300 (HuR) and 1:500 (GAPDH) and specific peroxidase-conjugated secondary antibodies at a concentration of 1:1,000. Protein bands were documented using a gel documentation system (UVITech, Cambridge, UK).
In vitro growth assay. Cells (3,000) from the HuR knockdown and PEF control cell line were seeded into a 96-well plate in triplicate. Cells were then incubated for 1, 3 and 5 days before being fixed in 4% formaldehyde (v/v) and stained with 0.5% (w/v) crystal violet. The crystal violet stain was then extracted using 10% acetic acid (v/v) and cell density was determined by measuring the absorbance of this solution at a wavelength of 540 nm using an EL x800 spectrophotometer (Bio-Tek Instruments Inc., Winooski, VT, USA). Data was normalised using day 1 absorbance to account for any seeding bias.
Analysis of cell cycle. Cells (500,000) were seeded into a large flask (75 cm 2 ) in normal medium on day 0. On day 1, the normal medium was replaced with serum-free medium to 
CTGAGTACGTCGTGGAGTC ACTGAACCTGACCGTACACAGAGATGATGACCCTTTTG arrest cellular proliferation in the G0 phase. On the evening of day 3, the medium was changed back to normal to restart cellular proliferation. Sixteen hours later, the cells were collected, fixed in 70% ethanol at 4˚C for 2 h, resuspended in 1 ml of PI staining solution, and incubated for 15 min at 37˚C. The samples were then analysed using the Partec CyFlow ® SL flow cytometer and the accompanied FloMax software package (Partec GmbH, Munich, Germany). The cell cycle was determined using DNA content to label cells in either the G0/1, S or G2/M phase of replication.
Analysis of apoptosis. Cells (150,000 or 300,000) were seeded into 25-cm 2 flasks labelled normal or serum-free medium, respectively, and initially filled with normal medium. On day 1 the medium was changed in all flasks to either normal or serum-free, as appropriate. On day 4, all cells were harvested, including the cells floating in the culture medium, and resuspended in 1X Annexin-binding buffer at a concentration of ~1x10 6 cells/ml. FITC annexin V (5 µl) and 1 µl of the PI working solution (100 µg/ml, supplied by Vybrant ® ) was added to each 100 µl of cell suspension, and the cells were incubated at 37˚C for 15 min. Annexin binding buffer 1X (400 µl) was then added prior to processing, which was performed using the Partec CyFlow ® SL flow cytometer and the accompanied FloMax software package (Partec GmbH).
Electric cell-substrate impedance sensing (ECIS) adhesion and motility assay. The ECIS 1600R model instrument and 8W10 arrays (Applied Biophysics, Inc., Troy, NJ, USA) were used, as previously described (24) . Following treatment of the surface with a cysteine solution, the arrays were incubated with complete medium for 1 h. The same number of HaCaT cells (40,000) was added to each well. After reaching confluence, the cells were subject to wounding using the integrated elevated field module in the instrument in the 1600R model (5 V, 30 sec). Changes in cellular impedance were recorded during initial attachment and following wounding at 4,000 Hz.
Statistical analysis. Experimental procedures were repeated independently a minimum of three times. Data were analysed using the Minitab 14 software, and statistical comparisons were drawn using the two-sample, two-tailed t-test or the Mann-Whitney non-parametric test as appropriate. P<0.05 was considered to denote statistical significance. 
Results
Expression levels of HuR transcripts in wound tissues
Knockdown of HuR expression in HaCaT cells.
In order to further evaluate HuR function in vitro, we screened the human keratinocyte cell line for presence of HuR. After confirming that HuR was expressed in the HaCaT cells, we created a HaCaT HuR knockdown cell line and the control HaCaT PEF cell line (empty plasmid control) using stable transfection, as described above. After 2 weeks of cell culture in selection medium, mRNA was extracted from both cell lines. Standard PCR confirmed a reduction in HuR mRNA level in the HuR knockdown cell line compared to the PEF cell line, and subsequent Western blotting confirmed that HuR expression was also reduced at the protein level (Fig. 2) .
Effect of HuR knockdown on growth, cell cycle and apoptosis.
HuR has been shown to alter growth rates in cancer cell lines (25) . After confirmation of knockdown, we analysed growth using a standard 5-day growth assay. When normalised to data from day 1, HuR knockdown cells demonstrated a consistently faster rate of growth when compared to the PEF cell line (P<0.0001; Fig. 3A) .
In order to further clarify the mechanism via which HuR has its effect on growth, we analysed the effect of HuR knockdown on cell cycle and apoptosis. Cell cycle was analysed using the Partec CyFlow ® SL flow cytometer. HuR knockdown resulted in a greater portion of cells progressing to the S and G2/M phase, compared to the PEF control (Fig. 3B) . This would be consistent with the increased growth rate observed in the HuR knockdown cell line. 
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We also analysed the effect of HuR knockdown on apoptosis. When cultured under normal conditions, HuR knockdown had minimal effect on apoptosis (Fig. 3C) . When cultured in serum-free medium, HuR knockdown resulted in reduced levels of apoptosis, with a corresponding increase in live cells (Fig. 3D) . Again, this would be consistent with the increased growth rate observed in the HuR knockdown cell line.
Analysis of adhesion and migration.
We analysed the effect of HuR knockdown on both adhesion and migration using ECIS. Once cells were seeded, the internal resistance of each well was measured at regular intervals. As cells adhere to the electrode, resistance increases. We analysed normalised resistance at 4 h, as shown in Fig. 3 . This demonstrated a significantly reduced rate of adhesion of the HuR knockdown cell line (P=0.02; Fig. 3E ).
After the resistance for each well had plateaued, typically after 6-8 h, the monolayer was wounded using the integrated elevated field module. We found that the optimum wound is created using 5 V for 30 sec for each well. Following wounding, the resistance reaches its nadir, which is subsequently recorded as time zero, and against which all subsequent readings are normalised. We found that knockdown of HuR had no significant effect on rates of migration when compared to the PEF control (P=0.16; Fig. 3F ).
Discussion
Successful wound healing requires the coordination of a number of processes to ensure timely closure of a wound. In recent years, greater attention has been given to molecular changes within keratinocytes on the edge of chronic wounds. 
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Certain authors have explored variations in gene expression at the wound edge using microarray technology, searching for distinctive gene signatures and molecular patterns found in the keratinocytes bordering healing and non-healing wounds. For example, Cole et al (26) analysed the expression of mRNA in normal and acutely wounded skin from healthy volunteers at 30 and 60 min after wounding. They found that 124 (3%) out of the 4,000 genes investigated (primarily involved in transcription and signalling) demonstrated a significant increase from baseline (2 times) at 30 min (with no genes significantly down-regulated). At 60 min, 46 (1.15%) out of the 4,000 genes were significantly overexpressed, but 264 (6.6%) out of the 4,000 genes (a number of which have unknown functions) were down-regulated. These findings help delineate the molecular changes occurring in the acute response to wounding. Other authors have used similar methods to evaluate the gene signatures of healing and non-healing wounds (27) .
We recently investigated the effects of individual genes on wound healing using both in vitro and in vivo data. For example, Ehm2 (expressed in highly metastatic cells 2) was found to be up-regulated in acute wounds compared to chronic wounds. Further in vitro analysis showed that Ehm2 promotes HaCaT motility, without affecting growth rates (28) . Analysis of individual genes allows for a greater understanding of the molecular mechanisms behind the abnormal cellular behaviour noted in chronic wounds, and allows for identification of potential treatment targets.
HuR is a well-known post-transcriptional regulator of mRNAs rich in AREs (15) . By shuttling these inherently unstable mRNAs from the nucleus to the cytoplasm, HuR affects a number of key cellular processes. Target mRNAs include the cell cycle regulators c-myc (29) , cyclin A and B1 (30) and cyclin E1 (31), as well as angiogenic promoters and proto-oncogenes (15) .
HuR has been extensively evaluated in cancer. Elevated levels have been associated with a poorer prognosis in a number of neoplastic processes, including colonic (10), breast (11), ovarian (12, 13) and gastric carcinoma (14) . HuR expression appears to enhance the progression of cancer by up-regulating cellular proliferation, angiogenesis, invasion and migration (15) . It is well-known that cancer and wound healing share a number of similar cellular changes, albeit occurring in an uncoordinated fashion in cancer (32, 33) . We thus hypothesised that HuR would be up-regulated in healing wounds.
Our study is the first to investigate HuR with regards to wound healing using the HaCaT keratinocyte cell line. We showed that, as predicted, HuR expression was higher in chronic healed wounds compared to chronic non-healed wounds, although this failed to reach statistical significance. HuR knockdown increased growth in the HaCaT cell line, implying that elevated HuR levels reduce cellular growth. Furthermore, we demonstrated that this increased growth rate was due to more rapid progression through the cell cycle in the knockdown cell line, and a partial reduction in rates of apoptosis. When HuR expression is reduced in cancerous cell lines, growth is typically inhibited, as is cell cycle progression (25, 30) . Thus, HuR knockdown results in markedly differing behaviour in the non-malignant HaCaT cell line compared to cancerous cell lines. Our research group has found similar differences between malignant and non-malignant cell lines with other proteins.
For example, Ehm2 knockdown was found to inhibit growth in MCF-7 breast cancer cells by increasing apoptosis (34) , whereas a similar knockdown in HaCaT cells had no effect on either growth or apoptosis (28) . These data highlight the importance of caution when assuming that wound healing pathways function in an identical manner to cancerous pathways.
HuR knockdown reduces cellular adhesion, with minimal affect on migration. HuR thus functions as a pro-adhesive protein in the HaCaT cell line. Re-epithelialisation is characterized by epithelial migration, in which the adhesion of epithelial cells to the ECM plays a prominent role (35, 36) . It is most likely that this effect on adhesion is the mechanism through which HuR promotes wound healing.
In conclusion, this is the first study to specifically analyse HuR in the context of wound healing. Elevated HuR levels are associated with a non-significant trend towards increased healing in vivo. We used a stably transfected HuR knockdown cell line to further evaluate the role of HuR in wound healing. In vitro data suggest that HuR reduces cellular growth, slows cell cycle progression and increases apoptosis. Furthermore, HuR improves cellular adhesion, a possible mechanism through which it enhances wound healing.
